Mirae Asset Global Investments
NUVB icon

Mirae Asset Global Investments’s Nuvation Bio NUVB Stock Holding History

Mirae Asset Global Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-45,133
Closed -$146K – 2643
2022
Q2 		$146K Buy
+45,133
New +$197K ﹤0.01% 2237

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments's NUVB Position: Q3 2022 in Review

Mirae Asset Global Investments sold out of Nuvation Bio (NUVB) in Q3 2022, closing a stake of 45,133 shares — an estimated $146K sold.

Mirae Asset Global Investments first reported a position in NUVB in Q2 2022 and held it in 1 quarter. The position peaked at $146K in Q2 2022. 121 funds tracked by Wall St. Rank hold NUVB as of Q3 2022.

  • Mirae Asset Global Investments reported no remaining Nuvation Bio position as of Q3 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 45,133 Nuvation Bio shares in Q3 2022, an estimated $146K.
  • Mirae Asset Global Investments first reported a position in Nuvation Bio in Q2 2022 and held it in 1 quarter.
  • Mirae Asset Global Investments's Nuvation Bio position peaked at $146K in Q2 2022.
  • 121 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2022.

Based on Mirae Asset Global Investments's 13F filing for Q3 2022, filed 10 Nov 2022.